|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 5/08/20 Biolase, Inc 10-Q 3/31/20 86:8.5M ActiveDisclosure/FA |
Document/Exhibit Description Pages Size
1: 10-Q Quarterly Report HTML 638K
4: EX-10.10 Material Contract HTML 30K
2: EX-10.8 Material Contract HTML 63K
3: EX-10.9 Material Contract HTML 30K
5: EX-31.1 Certification -- §302 - SOA'02 HTML 32K
6: EX-31.2 Certification -- §302 - SOA'02 HTML 32K
7: EX-32.1 Certification -- §906 - SOA'02 HTML 26K
8: EX-32.2 Certification -- §906 - SOA'02 HTML 26K
21: R1 Document and Entity Information HTML 78K
69: R2 Consolidated Balance Sheets (Unaudited) HTML 114K
78: R3 Consolidated Balance Sheets (Unaudited) HTML 51K
(Parenthetical)
50: R4 Consolidated Statements Of Operations And HTML 95K
Comprehensive Loss (Unaudited)
20: R5 Consolidated Statements Of Redeemable Preferred HTML 53K
Stock and Stockholders' (Deficit) Equity
(Unaudited)
68: R6 Consolidated Statements Of Cash Flows (Unaudited) HTML 110K
77: R7 Description of Business and Basis of Presentation HTML 47K
49: R8 Summary of Significant Accounting Policies HTML 39K
22: R9 Revenue Recognition HTML 165K
63: R10 Redeemable Preferred Stock and Stockholders' HTML 243K
(Deficit) Equity
71: R11 Inventory HTML 46K
48: R12 Property, Plant, and Equipment HTML 67K
19: R13 Intangible Assets and Goodwill HTML 29K
62: R14 Accrued Liabilities HTML 87K
70: R15 Debt HTML 98K
47: R16 Leases HTML 79K
18: R17 Commitments and Contingencies HTML 35K
61: R18 Segment Information HTML 61K
72: R19 Concentrations HTML 74K
42: R20 Income Taxes HTML 31K
34: R21 Subsequent Event HTML 31K
60: R22 Summary of Significant Accounting Policies HTML 219K
(Policies)
86: R23 Revenue Recognition (Tables) HTML 206K
41: R24 Redeemable Preferred Stock and Stockholders' HTML 247K
(Deficit) Equity (Tables)
33: R25 Inventory (Tables) HTML 47K
59: R26 Property, Plant, and Equipment (Tables) HTML 66K
85: R27 Accrued Liabilities (Tables) HTML 88K
43: R28 Debt (Tables) HTML 75K
32: R29 Leases (Tables) HTML 80K
15: R30 Segment Information (Tables) HTML 62K
45: R31 Concentrations (Tables) HTML 118K
73: R32 Description of Business and Basis of Presentation HTML 56K
- Additional Information (Detail)
64: R33 Revenue Recognition - Additional Information HTML 34K
(Detail)
16: R34 Summary of Opening and Closing Balances of HTML 37K
Contract Liabilities (Detail)
46: R35 Summary of Disaggregation of Revenues Related to HTML 32K
Geographic Areas (Detail)
74: R36 Summary of Revenues Disaggregated by Timing of HTML 32K
Goods and Services Transferred (Detail)
65: R37 Summary of Sales by End Market (Detail) HTML 32K
17: R38 Schedule of Revenue and Percentages of Revenue HTML 49K
Sales by Product Line (Detail)
44: R39 Redeemable Preferred Stock and Stockholders' HTML 79K
(Deficit) Equity - Additional Information (Detail)
29: R40 Classification of Compensation Expense Associated HTML 37K
with Share-Based Payments (Detail)
39: R41 Assumptions Used in Estimating Fair Value of Stock HTML 33K
Options Granted (Detail)
80: R42 Summary of Option Activity (Detail) HTML 59K
54: R43 Summary of Unvested Stock Option Activity (Detail) HTML 46K
30: R44 Cash Proceeds Along with Fair Value Disclosures HTML 33K
Related to Grants, Exercises and Vested Options
(Detail)
40: R45 Summary of Unvested Restricted Stock Units HTML 50K
(Detail)
81: R46 Summary of Warrant Activity (Detail) HTML 37K
55: R47 Components of Inventory (Detail) HTML 35K
31: R48 Inventory - Additional Information (Detail) HTML 28K
37: R49 Summary of Property, Plant, and Equipment (Detail) HTML 49K
52: R50 Property, Plant, and Equipment - Additional HTML 27K
Information (Detail)
26: R51 Intangible Assets and Goodwill - Additional HTML 33K
Information (Detail)
67: R52 Components of Accrued Liabilities (Detail) HTML 48K
76: R53 Changes in Initial Product Warranty Accrual and HTML 41K
Expenses Under Initial and Extended Warranties
(Detail)
51: R54 Accrued Liabilities - Additional Information HTML 33K
(Detail)
25: R55 Debt - Summary of Principal Outstanding and HTML 33K
Unamortized Discount (Detail)
66: R56 Debt - Additional Information (Detail) HTML 224K
75: R57 Debt - Summary of Future Minimum Principal and HTML 47K
Interest Payments (Detail)
53: R58 Leases - Additional Information (Detail) HTML 64K
23: R59 Leases - Information related to Right-of-use HTML 29K
Assets and Liabilities (Detail)
58: R60 Leases - Schedule of Maturities of Lease HTML 37K
Liabilities (Detail)
83: R61 Leases - Future Minimum Rental Commitments Under HTML 44K
Lease Agreements (Detail)
36: R62 Commitments and Contingencies - Additional HTML 57K
Information (Detail)
28: R63 Segment Information - Additional Information HTML 38K
(Detail)
57: R64 Summary of Net Revenue by Geographic Location HTML 32K
(Detail)
82: R65 Summary of Property, Plant and Equipment by HTML 33K
Geographic Location (Detail)
35: R66 Concentrations - Summary of Net Revenue from HTML 49K
Various Products (Detail)
27: R67 Concentrations - Additional Information (Detail) HTML 40K
56: R68 Income Taxes - Additional Information (Detail) HTML 36K
84: R69 Subsequent Event - Additional Information (Detail) HTML 51K
24: XML IDEA XML File -- Filing Summary XML 152K
38: EXCEL IDEA Workbook of Financial Reports XLSX 89K
9: EX-101.INS XBRL Instance -- biol-20200331 XML 2.24M
11: EX-101.CAL XBRL Calculations -- biol-20200331_cal XML 170K
12: EX-101.DEF XBRL Definitions -- biol-20200331_def XML 543K
13: EX-101.LAB XBRL Labels -- biol-20200331_lab XML 1.33M
14: EX-101.PRE XBRL Presentations -- biol-20200331_pre XML 1.01M
10: EX-101.SCH XBRL Schema -- biol-20200331 XSD 205K
79: ZIP XBRL Zipped Folder -- 0001564590-20-023480-xbrl Zip 165K
Exhibit 31.2
CERTIFICATION
I, John R. Beaver, certify that:
|
1. |
I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2020 of BIOLASE, Inc.; |
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
a. |
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
b. |
Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
c. |
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
d. |
Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
|
5. |
I have disclosed, based on my most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
|
a. |
All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
|
b. |
Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
|
Date: May 8, 2020 |
By: |
/s/ JOHN R. BEAVER |
|
|
|
|
|
|
|
Executive Vice President and Chief Financial Officer |
| This ‘10-Q’ Filing | Date | Other Filings | ||
|---|---|---|---|---|
 | ||||
| Filed on: | 5/8/20 | |||
| For Period end: | 3/31/20 | 8-K | ||
| List all Filings | ||||